Asahi Enterprise to ratify name change certificate at EGM on Oct 30
- EGM scheduled for October 30, 2026, to ratify CA certificate for name change
- Name changed from Global Longlife Hospital to Asahi Enterprise Limited
- Investment in new activity of ₹1,702.15 lakh exceeds 50% of total assets
- Total assets stood at ₹2,372.98 lakh as of June 30, 2026

*this image is generated using AI for illustrative purposes only.
Asahi Enterprise Limited , formerly known as Global Longlife Hospital and Research Limited, has scheduled an Extra Ordinary General Meeting (EGM) for Friday, October 30, 2026. The meeting aims to ratify the submission of a Practicing Chartered Accountant’s certificate required under Regulation 45 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in connection with the company’s recent name change.
The EGM will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) at 12:15 pm IST. The primary agenda item involves a Special Resolution to approve the acts done by the Board of Directors in obtaining and submitting the CA certificate confirming compliance with regulatory conditions for changing the company’s name from Global Longlife Hospital and Research Limited to Asahi Enterprise Limited.
Background of the Name Change
The shareholders had previously approved the name change at the Annual General Meeting held on June 25, 2026. However, the specific CA certificate mandated by BSE Limited and SEBI regulations was inadvertently omitted from the explanatory statement of that AGM notice. Consequently, the company received in-principle approval from BSE Limited on August 27, 2026, and the Registrar of Companies issued the Certificate of Incorporation for the new name on September 25, 2026. This EGM seeks to retrospectively ratify the submission of the missing certificate to ensure full regulatory compliance.
Financial Compliance Details
To satisfy Regulation 45(1)(c), which requires that the amount invested in the new activity is at least fifty percent of the assets of the listed entity, the company provided a detailed breakdown of its financial position as of June 30, 2026. The certificate issued by M/s MSNJ & Associates confirmed that the investment in the new activity exceeded the threshold.
| Particulars | Amount (₹ lakh) |
|---|---|
| Total Assets | 2,372.98 |
| 50% of Total Assets | 1,186.49 |
| Investment in New Activity | 1,702.15 |
The components of assets included Cash and Cash Equivalents of ₹1,702.15 lakh, which constituted 71.73% of total assets. Other current assets totaled ₹2,261.92 lakh, while preliminary expenses stood at ₹111.07 lakh.
What the Numbers Show
The compliance with Regulation 45(1)(c) relies heavily on the composition of the company's current assets. With Cash and Cash Equivalents accounting for ₹1,702.15 lakh out of total assets of ₹2,372.98 lakh, cash holdings represent over 71% of the balance sheet. This high liquidity position allows the company to meet the requirement that investments in the new activity exceed 50% of total assets, despite the lack of significant tangible fixed assets or long-term investments disclosed in the immediate asset breakdown.
Historical Stock Returns for Global Longlife Hospital & Research
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.87% | -8.50% | 0.0% | -15.67% | 0.0% | -90.93% |
What specific new business activities will Asahi Enterprise Limited pursue to deploy the ₹1,702.15 lakh in cash reserves, given the pivot from a hospital and research focus?
How will the retrospective ratification of the CA certificate impact the company's standing with SEBI regarding future compliance audits and potential regulatory scrutiny?
Does the high proportion of cash assets (71.73%) suggest a potential acquisition strategy or a shift toward a holding company model rather than operational healthcare services?


































